Suat Gezer

Suat Gezer

Auto-generated profile, based on publicly available information

Suat Gezer

ÇUKUROVA ÜNİVERSİTESİ, TIP FAKÜLTESİ

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2019 in Dicle Tıp Dergisi
Verified
Journal Article
Open access
PDF file
MTMediha Turktan
Mediha Turktan
AAAlper Avci
Alper Avci
SGSuat Gezer
Suat Gezer
OSOrhan Kemal Sali̇h
Orhan Kemal Sali̇h
Mediastinoskopi; mediastinal lenf noduevrelemesi için gelişmiş görüntüleme yöntemlerine karşın (transtorasik iğne aspirasyonu, torakoskopik biyopsi, endoskopik ince iğne aspirasyonu gibi) halen altın standart olmaya devam etmektedir. Genellikle güvenli bir işlem olmasına rağmen, pnömotoraks, sol rekürren sinir hasarı, trakeal ya da özefagialrüptür ve büyük damar yaralanması nadir görülen ancak korkulan komplikasyonlardır.Mortaliteye sebep olan en önemli komplikasyonu ise major kanamadır. Bu olgu sunumunda mediastinoskopi sırasında ciddi kanama gelişen ve kardiyopulmoner bypass altında onarım yapılan iki olgunun anestezik yaklaşımı tartışılmıştır.

31 December 2023 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Verified
Journal Article
Open access
PDF file
IKİsmail Can Karacaoğlu
İsmail Can Karacaoğlu
CÖCemal Özçeli̇k
Cemal Özçeli̇k
AAAlper Avci̇
Alper Avci̇
SGSuat Gezer
Suat Gezer
Objective: In this study, our aim was to examine the impact of unexpected N2 and potentially resectable N2 groups, which were categorized based on the clinical approach to N2 lymph node involvement, on the survival outcomes of patients who underwent lung resection for non-small cell lung cancer. Specifically, we focused on identifying patients with ipsilateral mediastinal metastatic lymph nodes (N2) and assessing their survival rates. Material and Method: A retrospective cohort study was conducted at a single center, comprising a total of 953 patients who underwent anatomical lung resection and mediastinal lymph node dissection for non-small cell lung cancer (NSCLC) between the years 2011 and 2017. Results: Between January 2011 and December 2017, a retrospective review was conducted on 953 patients who underwent lung resection for non-small cell lung cancer (NSCLC) at our hospital. Patients were categorized into three groups: patients without initial clinical N2 involvement but with postoperative pathological N2 involvement (group 1), patients with initial clinical N2 involvement who underwent immediate surgery (group 2), and patients with initial clinical N2 involvement who demonstrated stable pathological N2 involvement or partial regression after receiving neoadjuvant chemotherapy or chemoradiotherapy and subsequently underwent surgery (group 3). A total of 71 patients (7.45% of the cohort) with postoperative pN2 were included in this study. Among these 71 patients, 41 (57.74%) did not have initial cN2 involvement and were categorized as postoperative pN2 (group 1). Twenty patients (28.16%) with a single cN2 were considered as carefully selected patients and underwent surgery (group 2). Ten patients (14.08%) were selected patients who received neoadjuvant treatment and subsequently had a single N2 involvement, and they underwent anatomical resection (group 3). Statistical analysis revealed no significant differences in survival between the three groups (p=0.882). Conclusion: No consensus currently exists regarding the role of surgery in the management of patients with NSCLC and mediastinal lymph node metastases. Existing evidence suggests that studies encompassing larger patient cohorts are necessary to comprehensively investigate the subgroups of patients with N2 disease.

31 March 2021
Verified
Book Chapter
Open access
PDF file
SGSuat Gezer
Suat Gezer

15 August 2022 in Journal of Bionic Memory
Verified
Journal Article
Closed access
IKIsmail Can Karacaoglu
Ismail Can Karacaoglu
SGSuat Gezer
Suat Gezer